Amit Sachdev - Feb 10, 2023 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Chief Patient Officer
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2023
Transactions value $
-$2,157,492
Form type
4
Date filed
2/14/2023, 04:06 PM
Previous filing
Feb 3, 2023
Next filing
Feb 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$768K -2.61K -3.27% $294.33 77.1K Feb 10, 2023 Direct
transaction VRTX Common Stock Tax liability -$1.39M -4.66K -6.04% $298.26 72.5K Feb 13, 2023 Direct
holding VRTX Common Stock 882 Feb 10, 2023 401(k)
holding VRTX Common Stock 8.86K Feb 10, 2023 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.